Medley (4480) AI Stock Analysis

• Market Cap: €70.97B
• Dividend Yield: N/A
• Average Volume (3M): 504.45K
• Price to Earnings (P/E): 48.8
• Beta (1Y): 0.62
• Revenue Growth: 34.77%
• EPS Growth: -46.50%
• Country: JP
• Employees: 1,487
• Sector: Healthcare
• Sector Strength: 45
• Industry: Medical - Healthcare Information Services
• EPS (TTM): 22.39
• Shares Outstanding: 32,738,600
• 10 Day Avg. Volume: 497,800
• 30 Day Avg. Volume: 504,450
• PEG Ratio: 5.33
• Price to Book (P/B): 6.16
• Price to Sales (P/S): 4.25
• P/FCF Ratio: 52.31
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: €4,482.21
• Price Target Upside: 112.83% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 1

• Rating: 61 Neutral
• Price Target: ¥2,181.00 ▲(3.56% Upside)

Medley, Inc. demonstrates strong financial performance, which is the most significant factor supporting its stock score. However, bearish technical indicators and an overvalued P/E ratio weigh down the overall score. The lack of earnings call insights and corporate events means these factors do not influence the score.

Medley Business Overview & Revenue Model

Company Description

Medley (4480) is a healthcare company focused on providing innovative solutions in the telehealth and digital health sectors. The company specializes in offering a range of services including virtual consultations, remote patient monitoring, and digital therapeutics, aimed at improving patient outcomes and enhancing access to healthcare services. Medley leverages technology to connect patients with healthcare providers, streamline healthcare delivery, and support chronic disease management.

How the Company Makes Money

Medley generates revenue primarily through subscription fees for its telehealth platform, where healthcare providers pay for access to the software and services that facilitate virtual care. Additionally, the company earns income from per-visit fees charged to patients for virtual consultations. Key revenue streams include partnerships with healthcare organizations and insurance companies that integrate Medley's services into their offerings, as well as monetization of data insights gathered from patient interactions to improve healthcare delivery and outcomes. The company's growth is further supported by strategic collaborations with technology firms to enhance its platform capabilities and expand its market reach.

Medley Financial Statement Overview

Summary

Medley, Inc. is in a strong financial position with impressive revenue and profit growth, stable cash flow generation, and a well-capitalized balance sheet. While there are areas to monitor, such as operational efficiency and investment returns, the overall financial health supports continued growth.

Income Statement

Medley, Inc. has demonstrated strong revenue growth, with a significant increase from 2023 to 2024, indicating a positive growth trajectory. The gross profit margin remains robust, and the net profit margin is healthy, reflecting efficient cost management. However, the slight decline in EBIT margin suggests potential pressure on operational efficiency.

Balance Sheet

The company's balance sheet is stable, with a solid equity base and a healthy debt-to-equity ratio, indicating low financial leverage. The equity ratio is also strong, reflecting a well-capitalized structure. However, the increase in total liabilities warrants monitoring, as it could impact future financial flexibility.

Cash Flow

Medley, Inc. exhibits strong cash flow generation, with positive free cash flow and a favorable operating cash flow to net income ratio. The free cash flow growth rate is commendable, suggesting efficient capital expenditure management. Despite this, the significant negative investing cash flow highlights substantial investments, which could pose risks if not yielding expected returns.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	33.06B	29.30B	20.53B	14.19B	10.86B	6.83B
Gross Profit	20.74B	18.92B	13.59B	9.72B	6.99B	4.67B
EBITDA	5.03B	4.00B	4.50B	2.14B	1.25B	586.57M
Net Income	1.44B	2.80B	2.57B	1.02B	563.00M	455.99M
Balance Sheet
Total Assets	47.42B	45.20B	25.43B	21.81B	20.21B	15.52B
Cash, Cash Equivalents and Short-Term Investments	13.52B	19.00B	15.35B	14.42B	14.29B	14.05B
Total Debt	18.27B	15.18B	1.66B	2.38B	3.11B	4.18B
Total Liabilities	29.36B	24.98B	7.79B	6.64B	6.16B	5.80B
Stockholders Equity	18.07B	20.21B	17.55B	15.08B	13.97B	9.72B
Cash Flow
Free Cash Flow	0.00	2.38B	3.47B	1.64B	796.39M	591.87M
Operating Cash Flow	0.00	2.45B	3.87B	2.01B	1.04B	805.76M
Investing Cash Flow	0.00	-10.72B	-1.66B	-751.00M	-3.29B	-283.15M
Financing Cash Flow	0.00	11.90B	-1.22B	-927.00M	2.22B	9.05B

Medley Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 2106.00
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4480, the sentiment is Negative. The current price of 2106 is below the 20-day moving average (MA) of 2273.00, below the 50-day MA of 2402.66, and below the 200-day MA of 3031.66, indicating a bearish trend. The MACD of -86.87 indicates Positive momentum. The RSI at 35.93 is Neutral, neither overbought nor oversold. The STOCH value of 12.21 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:4480.

Medley Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
4483	―	¥313.56B	49.34	―	0.33%	29.09%	87.01%
2175	―	¥116.54B	15.07	―	2.18%	7.27%	13.49%
3939	―	¥22.81B	22.43	―	1.56%	13.39%	12.00%
4480	―	€70.97B	48.83	8.00%	―	34.77%	-46.50%
Sector *	―	$7.86B	-0.30	-43.30%	2.27%	22.53%	-2.21%
4263	―	¥15.41B	―	―	―	35.15%	16.89%
3902	―	¥17.78B	-24.30	―	1.55%	-0.58%	-260.22%

Medley Corporate Events

Medley, Inc. Announces Merger with ASFON TRUST NETWORK Inc.

Medley, Inc. announced a merger with its wholly owned subsidiary, ASFON TRUST NETWORK Inc., to enhance synergies and accelerate growth. The merger will result in an extraordinary loss due to the extinguishment of tie-in shares, but it is expected to strengthen the company’s operations and market positioning.

The most recent analyst rating on (JP:4480) stock is a Hold with a Yen2374.00 price target. To see the full list of analyst forecasts on Medley stock, see the JP:4480 Stock Forecast page.

Medley, Inc. Completes Strategic Share Repurchase

Medley, Inc. has completed a share repurchase program, acquiring 187,300 common shares for approximately 457 million yen through market transactions on the Tokyo Stock Exchange. This move is part of Medley’s flexible capital policy aimed at adapting to market conditions and optimizing shareholder returns, with the company indicating potential future repurchases.

The most recent analyst rating on (JP:4480) stock is a Buy with a Yen5600.00 price target. To see the full list of analyst forecasts on Medley stock, see the JP:4480 Stock Forecast page.

Medley, Inc. Expands Share Repurchase Program

Medley, Inc. has announced an expansion of its share repurchase framework and an extension of the repurchase period to enhance shareholder returns and adapt to market trends. The company plans to increase the number of shares repurchased to 1,050,000 and the aggregate repurchase amount to 3,000 million yen, with the period extended until December 31, 2025.

The most recent analyst rating on (JP:4480) stock is a Buy with a Yen7400.00 price target. To see the full list of analyst forecasts on Medley stock, see the JP:4480 Stock Forecast page.

Medley Records Extraordinary Loss Post-Merger

Medley, Inc. announced an extraordinary loss of 783 million yen due to an absorption-type merger with its wholly-owned subsidiaries, Offshore Inc. and GUPPY’s Inc. This loss, recorded in the non-consolidated financial statements for the first half of 2025, will not affect the company’s consolidated profit and loss, ensuring stability in its overall financial health.

The most recent analyst rating on (JP:4480) stock is a Buy with a Yen7400.00 price target. To see the full list of analyst forecasts on Medley stock, see the JP:4480 Stock Forecast page.